During the past decade, Midland Clinical Research Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midland Clinical Research Center" #1 sponsor was "Pfizer" with 2 trials, followed by "AstraZeneca" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midland Clinical Research Center" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Midland Clinical Research Center" are "Cardiovascular Disease" (3 trials), "Arthritis, Rheumatoid" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "High Cardiovascular Risk" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Midland Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Midland Clinical Research Center" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Dapagliflozin" (1 trials), "Ibuprofen" (1 trials) and "Lorcaserin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Midland Clinical Research Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Midland Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Midland Clinical Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Midland Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".